Evidence map›Paper›PMID 32647304›Full record

ArticleScientific reports2020

HOPX regulates bone marrow-derived mesenchymal stromal cell fate determination via suppression of adipogenic gene pathways.

Chee Ho Hng, Esther Camp, Peter Anderson, James Breen, Andrew Zannettino, Stan Gronthos

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Paracrine iron activates HopxJournal of advanced research · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Chee Ho HngMesenchymal Stem Cell Laboratory, South Australian Health and Medical Research Institute, North Terrace, Level 5, Adelaide, SA, 5001, Australia.
Esther Camp *Mesenchymal Stem Cell Laboratory, South Australian Health and Medical Research Institute, North Terrace, Level 5, Adelaide, SA, 5001, Australia.
Peter AndersonMesenchymal Stem Cell Laboratory, South Australian Health and Medical Research Institute, North Terrace, Level 5, Adelaide, SA, 5001, Australia.
James BreenMesenchymal Stem Cell Laboratory, South Australian Health and Medical Research Institute, North Terrace, Level 5, Adelaide, SA, 5001, Australia.
Andrew ZannettinoMesenchymal Stem Cell Laboratory, South Australian Health and Medical Research Institute, North Terrace, Level 5, Adelaide, SA, 5001, Australia.
Stan Gronthos *Mesenchymal Stem Cell Laboratory, South Australian Health and Medical Research Institute, North Terrace, Level 5, Adelaide, SA, 5001, Australia. stan.gronthos@adelaide.edu.au.
University of Adelaide · AUSouth Australian Health and Medical Research Institute · AUWomen's and Children's Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies of global binding patterns identified the epigenetic factor, EZH2, as a regulator of the homeodomain-only protein homeobox (HOPX) gene expression during bone marrow stromal cell (BMSC) differentiation, suggesting a potential role for HOPX in regulating BMSC lineage specification. In the present study, we confirmed that EZH2 direct binds to the HOPX promoter region, during normal growth and osteogenic differentiation but not under adipogenic inductive conditions. HOPX gene knockdown and overexpression studies demonstrated that HOPX is a promoter of BMSC proliferation and an inhibitor of adipogenesis. However, functional studies failed to observe any affect by HOPX on BMSC osteogenic differentiation. RNA-seq analysis of HOPX overexpressing BMSC during adipogenesis, found HOPX function to be acting through suppression of adipogenic pathways associated genes such as ADIPOQ, FABP4, PLIN1 and PLIN4. These findings suggest that HOPX gene target pathways are critical factors in the regulation of fat metabolism.

Indexed as

AdipogenesisOsteogenesisAdolescentAdultCell DifferentiationCell ProliferationCells, CulturedEnhancer of Zeste Homolog 2 ProteinFemaleHomeodomain ProteinsHumansMaleMesenchymal Stem CellsTumor Suppressor ProteinsYoung AdultEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanHomeodomain ProteinsHOPX protein, humanTumor Suppressor Proteins

Identifiers

PMID32647304
PMCPMC7347885
OpenAlexW3040856236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.